Journal of Magnetic Resonance Imaging

Journal

Publication Venue For

  • Imaging left-ventricular mechanical activation in heart failure patients using cine DENSE MRI: Validation and implications for cardiac resynchronization therapy.  46:887-896. 2017
  • Clinical application of PET/MRI in oncology.  44:265-276. 2016
  • Age-independent myocardial infarct quantification by signal intensity percent infarct mapping in swine.  43:911-920. 2016
  • MRI-based prostate volume-adjusted prostate-specific antigen in the diagnosis of prostate cancer.  42:1733-1739. 2015
  • Dynamic contrast-enhanced MRI evaluates the early response of human head and neck tumor xenografts following anti-EMMPRIN therapy with cisplatin or irradiation.  42:936-945. 2015
  • Left ventricular twist and shear in patients with primary mitral regurgitation.  42:400-406. 2015
  • Whole-body simultaneous positron emission tomography (PET)-MR: optimization and adaptation of MRI sequences..  39:259-268. 2014
  • Early therapy assessment of combined anti-DR5 antibody and carboplatin in triple-negative breast cancer xenografts in mice using diffusion-weighted imaging and 1H MR spectroscopy.  39:1588-1594. 2014
  • Measurement of interscapular brown adipose tissue of mice in differentially housed temperatures by chemical-shift-encoded water-fat MRI.  38:1425-1433. 2013
  • Three-dimensional plus time biventricular strain from tagged MR images by phase-unwrapped harmonic phase.  34:799-810. 2011
  • MR properties of brown and white adipose tissues.  34:468-473. 2011
  • Segmentations of MRI images of the female pelvic floor: A study of inter- and intra-reader reliability.  33:684-691. 2011
  • Identification of brown adipose tissue in mice with fat-water IDEAL-MRI.  31:1195-1202. 2010
  • 3D left ventricular strain from unwrapped harmonic phase measurements.  31:854-862. 2010
  • Percent infarct mapping for delayed contrast enhancement magnetic resonance imaging to quantify myocardial viability by Gd(DTPA)..  32:859-868. 2010
  • Magnetic resonance imaging for axillary staging in patients with breast cancer.  30:309-312. 2009
  • Measurements from image-based three dimensional pelvic floor reconstruction: A study of inter- and intraobserver reliability.  30:344-350. 2009
  • Head-to-head comparison between delayed enhancement and percent infarct mapping for assessment of myocardial infarct size in a canine model.  28:1386-1392. 2008
  • Simulation study of susceptibility gradients leading to focal myocardial signal loss.  28:1402-1408. 2008
  • Determining exercise-induced blood flow reserve in lower extremities using phase contrast MRI.  27:1096-1102. 2008
  • Abnormal hypermyelination in a neonate with sturge-weber syndrome demonstrated on diffusion-tensor imaging.  27:617-620. 2008
  • Open-chest 31P magnetic resonance spectroscopy of mouse heart at 4.7 Tesla.  24:1269-1276. 2006
  • In vivo R1-enhancement mapping of canine myocardium using CeMRI with Gd(ABE-DTTA) in an acute ischemia-reperfusion model.  24:571-579. 2006
  • Evaluation of in-stent stenosis by magnetic resonance phase-velocity mapping in nickel-titanium stents.  22:248-257. 2005
  • Magnetic resonance phase velocity mapping through NiTi stents in a flow phantom model.  21:59-65. 2005
  • Assessment of brain tumor angiogenesis inhibitors using perfusion magnetic resonance imaging: Quality and analysis results of a phase I trial.  20:913-922. 2004
  • Three-dimensional analysis of the geometry of individual multiple sclerosis lesions: Detection of shape changes over time using spherical harmonics.  18:291-301. 2003
  • An efficient MR phosphorous spectroscopic localization technique for studying ischemic heart.  10:892-898. 1999
  • An efficient MR phosphorous spectroscopic localization technique for studying ischemic heart.  10:892-898. 1999
  • On the stationary states in gradient echo imaging.  6:384-398. 1996
  • Regional myocardial blood volume and flow: First‐pass MR imaging with polylysine‐Gd‐DTPA.  5:227-237. 1995

    • International Standard Serial Number (issn)

  • 1053-1807

    • Electronic International Standard Serial Number (eissn)

  • 1522-2586